Our investigation commenced with the examination of differential expression between cancerous and healthy tissues, revealing a noteworthy decrease in FLT3LG expression in NSCLC compared with normal lung tissues, and the higher the expression is, the better the prognosis of patients. This evidence concerns the gene FLT3LG and non-small cell lung carcinoma.